How a virus modifies proteins to evade the immune response.

Antiviral responses of host mediated S-nitrosylation of viral proteins.

NIH-funded research Upstate Medical University · NIH-11035238

This study is looking at how the human cytomegalovirus (HCMV) changes its proteins to escape the body's defenses, with the hope of finding new ways to treat infections caused by this virus, which currently has no vaccine or cure.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUpstate Medical University NIH-funded
Lab location1 site (Syracuse, United States)
Project IDNIH-11035238 on NIH RePORTER

What this research studies

This research investigates how the human cytomegalovirus (HCMV) modifies its proteins through a process called S-nitrosylation to evade the host's antiviral responses. The study aims to understand the mechanisms behind these modifications and their effects on HCMV replication. By examining the interaction between HCMV proteins and the host's immune system, the research seeks to uncover potential therapeutic targets for treating infections caused by this virus. Patients may benefit from insights that could lead to new treatments for HCMV, especially since there is currently no vaccine or cure available.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals who are infected with human cytomegalovirus, particularly those with compromised immune systems.

Not a fit: Patients who are not infected with HCMV or those with fully functioning immune systems may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel therapies for HCMV infections.

How similar studies have performed: Other research has shown promise in understanding viral evasion strategies, making this approach both relevant and potentially impactful.

Where this research is happening

Syracuse, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.